keyboard_arrow_leftBack to Home
HD recorded lecture with live Q&A

Yale researchers report on study of the efficacy of the Alcat Test for patients with irritable bowel syndrome and the pathomechanisms of food sensitivity

Thursday, November 16, 5PM EST
Array
(
    [ID] => 1214
    [id] => 1214
    [title] => WajahatZafarMehalPhDMD
    [filename] => WajahatZafarMehalPhDMD.jpg
    [url] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD.jpg
    [alt] => Professor of Medicine (Digestive Diseases); Director of Yale Weight Loss Program
    [author] => 4
    [description] => Wajahat Zafar Mehal, PhD, MD
Professor of Medicine (Digestive Diseases); Director of Yale Weight Loss Program
    [caption] => Wajahat Zafar Mehal, MD, PhD, director of Yale Weight Loss Program
    [name] => wajahatzafarmehalphdmd
    [date] => 2017-11-01 18:12:13
    [modified] => 2017-11-01 18:13:34
    [mime_type] => image/jpeg
    [type] => image
    [icon] => https://cellsciencesystems.com/wp-includes/images/media/default.png
    [width] => 320
    [height] => 400
    [sizes] => Array
        (
            [thumbnail] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD-150x150.jpg
            [thumbnail-width] => 150
            [thumbnail-height] => 150
            [medium] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD.jpg
            [medium-width] => 240
            [medium-height] => 300
            [medium_large] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD.jpg
            [medium_large-width] => 320
            [medium_large-height] => 400
            [large] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD.jpg
            [large-width] => 320
            [large-height] => 400
            [small] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD.jpg
            [small-width] => 120
            [small-height] => 150
            [custom-size] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD-700x200.jpg
            [custom-size-width] => 700
            [custom-size-height] => 200
            [article-preview] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD-700x708.jpg
            [article-preview-width] => 700
            [article-preview-height] => 708
            [page-banner] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD-2560x610.jpg
            [page-banner-width] => 2560
            [page-banner-height] => 610
            [page-banner-tall] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD-2560x1465.jpg
            [page-banner-tall-width] => 2560
            [page-banner-tall-height] => 1465
            [speaker-peekture] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD-300x300.jpg
            [speaker-peekture-width] => 300
            [speaker-peekture-height] => 300
            [media-bar-image] => https://cellsciencesystems.com/wp-content/uploads/2017/11/WajahatZafarMehalPhDMD-447x252.jpg
            [media-bar-image-width] => 447
            [media-bar-image-height] => 252
        )

)
Professor of Medicine (Digestive Diseases); Director of Yale Weight Loss Program

Wajahat Zafar Mehal
PhD, MD

Event Detailskeyboard_arrow_down

Receive your invitation

Sorry, something went wrong. Please try again.

Please complete all fields before submitting this form.

Thank you for signing up!

Can't attend? Register and you'll receive the recording.

Event Details

Recently, researchers from the Yale School of Medicine published their evaluation of the efficacy of the Alcat Test for food sensitivity for management of patients with IBS. (Ali AWeiss TRMcKee Det al Efficacy of individualized diets in patients with irritable bowel syndrome: a randomized controlled trial. .

 

They reported on symptom outcome, proteomic evaluation on strong responders, and corollary inflammatory pathways.  Taken together this data sheds light on the pathomechanisms of cellular reactions to foods and use of a non-drug approach toward the management of a condition that afflicts approximately 15 – 20% of the US population.

Review complete study here. 

 

Please join us for a very exciting webinar on the research findings by Wajahat Mehal, PhD, MD, Head of the Digestive Disease Section at Yale School of Medicine, at, New Haven, CT , and followed by live questions and answers.

 

Dr. Wajahat Mehal is a gastroenterologist and the lead Professor of Medicine (Digestive Diseases) at the Yale School of Medicine and the Director of the Yale Weight Loss Program, obtained his MD and PhD (Immunology) from Oxford University Medical School, having completed his certification for AB of Internal Medicine for Gastroenterology in 2001. Dr. Mehal is involved in many departments and organizations including, Internal Medicine: Digestive Diseases; Hepatology: Viral Hepatitis Program; Metabolic Health and Weight Loss Program; Liver Center and more. He has performed extensive research into Sterile Inflammation, Liver Fibrosis, and Liver Immunology. His research is cited in almost a dozen publications.